ATE275409T1 - Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit - Google Patents

Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit

Info

Publication number
ATE275409T1
ATE275409T1 AT00122585T AT00122585T ATE275409T1 AT E275409 T1 ATE275409 T1 AT E275409T1 AT 00122585 T AT00122585 T AT 00122585T AT 00122585 T AT00122585 T AT 00122585T AT E275409 T1 ATE275409 T1 AT E275409T1
Authority
AT
Austria
Prior art keywords
crataegus
overweight
obesity
treatment
adrenergic activity
Prior art date
Application number
AT00122585T
Other languages
English (en)
Inventor
Bojidar M Stankov
Original Assignee
Ambros Pharma S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambros Pharma S R L filed Critical Ambros Pharma S R L
Application granted granted Critical
Publication of ATE275409T1 publication Critical patent/ATE275409T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00122585T 1999-10-20 2000-10-17 Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit ATE275409T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002201A IT1314199B1 (it) 1999-10-20 1999-10-20 Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'

Publications (1)

Publication Number Publication Date
ATE275409T1 true ATE275409T1 (de) 2004-09-15

Family

ID=11383822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00122585T ATE275409T1 (de) 1999-10-20 2000-10-17 Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit

Country Status (5)

Country Link
US (1) US6447818B1 (de)
EP (1) EP1093817B1 (de)
AT (1) ATE275409T1 (de)
DE (1) DE60013526T2 (de)
IT (1) IT1314199B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
FR2842425B1 (fr) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
US6565847B1 (en) * 2002-07-03 2003-05-20 Vitacost.Com, Inc. Thermogenic weight management composition
US7115285B2 (en) * 2003-03-14 2006-10-03 Eurark, Llc Composition and method for appetite and craving suppression and mood enhancement
US6861073B2 (en) * 2003-04-11 2005-03-01 Paul Ling Tai Dysfunctional satiety center syndrome and method of treatment therefor
FR2865652B1 (fr) * 2004-02-02 2009-10-02 Greenpharma Sas Utilisation d'extraits de plantes et de molecules purifiees pour des compositions cosmetique, nutraceutique ou pharmaceutique a action amincissante lipolytique.
WO2005089783A1 (ja) * 2004-03-22 2005-09-29 Shiseido Co., Ltd. リポプロテインリパーゼ活性抑制剤
BRPI0715109A2 (pt) * 2006-07-28 2013-06-04 Alberto Volcan composiÇço baseada em produtos vegetais, processo para a produÇço de couro artificial, e, couro artificial
WO2009054504A1 (ja) * 2007-10-24 2009-04-30 Suntory Holdings Limited ペルオキシソーム増殖剤応答性受容体（ｐｐａｒ）のリガンド剤
WO2017161379A1 (en) * 2016-03-18 2017-09-21 4Life Patents, Llc Methods and compositions for weight control
CN110772577A (zh) * 2019-12-20 2020-02-11 北京康比特体育科技股份有限公司 一种减肥组合物及其制备方法和用途
KR102697499B1 (ko) * 2020-06-22 2024-08-22 김병하 천연물질을 유효성분으로 포함하는 비만 예방 또는 치료를 위한 약제학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE901791C (de) * 1950-07-29 1954-01-14 Capehart Farnsworth Corp Fernsehkameraroehre
CN1122655A (zh) * 1994-11-05 1996-05-22 邓忠元 银杏叶系列袋泡茶
EP0885008B1 (de) * 1996-09-30 2009-12-30 Dennis Jones Regulation von Körpergewicht durch Materialien basierend auf Zitrusvariationen
US6224873B1 (en) * 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
ES2199474T3 (es) * 1997-11-14 2004-02-16 Warner-Lambert Company Llc Composicion farmaceutica que comprende (+)-efedrina y un antagonista del receptor h1.
JPH11228434A (ja) * 1998-02-09 1999-08-24 Pola Chem Ind Inc エネルギー利用促進剤
US6277396B1 (en) * 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance

Also Published As

Publication number Publication date
ITMI992201A0 (it) 1999-10-20
DE60013526T2 (de) 2005-11-17
IT1314199B1 (it) 2002-12-06
EP1093817B1 (de) 2004-09-08
DE60013526D1 (de) 2004-10-14
ITMI992201A1 (it) 2001-04-20
EP1093817A1 (de) 2001-04-25
US6447818B1 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
ATE275409T1 (de) Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit
US20060269567A1 (en) Universal detoxifying composition
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US20040185014A1 (en) Sleep inducing toothpaste made with natural herbs and a natural hormone
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
KR970061244A (ko) 치매 치료용 약학 조성물
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
KR19980072723A (ko) 한약 조성물 및 이의 제약학적 제제
RU2000114174A (ru) Применение фосфолипидных комплексов экстрактов из vitis vinifera в качестве противоатеросклеротических агентов
ATE182789T1 (de) Arzneimittelzusammensetzung zur prophylaxe und behandlung vorzeitigen samenergusses
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP1393738A4 (de) Arzneimittel gegen diabetes
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
DE50011533D1 (de) Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arznelmittel in Form von Tabletten
Bödigheimer et al. Effectiveness of hawthorn extract at a dosage of 3 x 100 mg per day. Multicentre double-blind trial with 85 NYHA stage II heart failure patients.
AU2003273444B2 (en) Use of Ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
CN101433576A (zh) 小儿止泻药膏
RU2243781C1 (ru) Биологически активная добавка для профилактики сердечно-сосудистых заболеваний
RU2259205C1 (ru) Лечебно-профилактическое средство при заболеванях мочеполовой системы у мужчин
Foster Herbal Remedies: Feverfew: When the Head Hurts
KR20040030376A (ko) 혈전 치료용 약제 조성물
Lichtenstein Improving HAART naturally
Cerrato Ginger (Zingiber officinale)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1093817

Country of ref document: EP

REN Ceased due to non-payment of the annual fee